A benefits case study describing how Diabetes UK has used HSCIC's data and statistical outputs to inform the Putting Feet First campaign. https://www.diabetes.org.uk/Get_involved/Campaigning/Our-campaigns/Putting-feet-first/
A benefits case study describing how national stakeholders have used HSCIC's immunisation statistics to help drive improvements in immunisation services and inform decisions when managing disease outbreaks
A benefits case study describing how national stakeholders have used HSCIC's immunisation statistics to help drive improvements in immunisation services and inform decisions when managing disease outbreaks
The purpose of this case study summary is to briefly describe how stakeholders have used the prescriptions dispensed in the community publication to inform analytical, reporting and contract negotiation activities.
The document discusses the importance of manufacturing to the UK pharmaceutical industry and the life sciences sector. It outlines the goals of the Medicines Manufacturing Industry Partnership (MMIP) in making the UK an attractive location for medicines manufacturing through initiatives like skills development programs. The document also notes industry's significant financial contributions to the NHS through the Pharmaceutical Price Regulation Scheme, and the importance of ensuring a regulatory framework that supports innovation as the UK leaves the EU.
Dr. Lauri Hicks - Out-Patient Antibiotic Resistance (AMR) IssuesJohn Blue
Out-Patient Antibiotic Resistance (AMR) Issues - Dr. Lauri Hicks, Commander, U.S. Public Health Service, Medical Epidemiologist, Respiratory Diseases Branch; Medical Director, Get smart: Know When Antibiotic Work Program; Centers for Disease Control and Prevention (CDC), from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
Cdc get smart week resident presentation 2014katejohnpunag
This document discusses antibiotic overuse and resistance. It notes that overuse of antibiotics can lead to adverse drug events, antibiotic resistance, and Clostridium difficile infections. It summarizes the 2013 CDC Threat Report on antibiotic resistance and lists several "superbugs" as major threats. The document advocates for antibiotic stewardship programs and lists seven ways healthcare providers can improve antibiotic prescribing practices to help address the growing crisis of antibiotic resistance.
Updates from the CDC - Michael Craig, Senior Advisor for Antibiotic Resistance Coordination and Strategy, National Center for Emerging and Zoonotic Infectious Diseases, CDC, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
Dr Caroline Brown, Programme Manager, Influenza and Other Respiratory Pathogens, Thomas Hofmann, IHR Area Coordinator, Communicable Diseases and Health Security
A benefits case study describing how national stakeholders have used HSCIC's immunisation statistics to help drive improvements in immunisation services and inform decisions when managing disease outbreaks
A benefits case study describing how national stakeholders have used HSCIC's immunisation statistics to help drive improvements in immunisation services and inform decisions when managing disease outbreaks
The purpose of this case study summary is to briefly describe how stakeholders have used the prescriptions dispensed in the community publication to inform analytical, reporting and contract negotiation activities.
The document discusses the importance of manufacturing to the UK pharmaceutical industry and the life sciences sector. It outlines the goals of the Medicines Manufacturing Industry Partnership (MMIP) in making the UK an attractive location for medicines manufacturing through initiatives like skills development programs. The document also notes industry's significant financial contributions to the NHS through the Pharmaceutical Price Regulation Scheme, and the importance of ensuring a regulatory framework that supports innovation as the UK leaves the EU.
Dr. Lauri Hicks - Out-Patient Antibiotic Resistance (AMR) IssuesJohn Blue
Out-Patient Antibiotic Resistance (AMR) Issues - Dr. Lauri Hicks, Commander, U.S. Public Health Service, Medical Epidemiologist, Respiratory Diseases Branch; Medical Director, Get smart: Know When Antibiotic Work Program; Centers for Disease Control and Prevention (CDC), from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
Cdc get smart week resident presentation 2014katejohnpunag
This document discusses antibiotic overuse and resistance. It notes that overuse of antibiotics can lead to adverse drug events, antibiotic resistance, and Clostridium difficile infections. It summarizes the 2013 CDC Threat Report on antibiotic resistance and lists several "superbugs" as major threats. The document advocates for antibiotic stewardship programs and lists seven ways healthcare providers can improve antibiotic prescribing practices to help address the growing crisis of antibiotic resistance.
Updates from the CDC - Michael Craig, Senior Advisor for Antibiotic Resistance Coordination and Strategy, National Center for Emerging and Zoonotic Infectious Diseases, CDC, from the 2016 NIAA Antibiotic Symposium - Working Together For Better Solutions, November 1 - 3, 2016, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2016-niaa-symposium-antibiotic-use-working-together-for-better-solutions
Dr Caroline Brown, Programme Manager, Influenza and Other Respiratory Pathogens, Thomas Hofmann, IHR Area Coordinator, Communicable Diseases and Health Security
Antibiotic resistance is a growing problem that threatens modern medicine. Antibiotic stewardship programs aim to optimize antibiotic treatment and reduce unnecessary use. Such programs coordinate antibiotic prescribing across healthcare facilities in a region to prevent the spread of resistant bacteria. Education is also key - medical students and society must be taught about appropriate antibiotic use and the consequences of misuse. With coordinated antibiotic stewardship and education, the spread of superbugs can be slowed.
This document provides an overview of the Meaningful Use program and regulations. It discusses the stages of Meaningful Use which focus on data capture, sharing, and advanced clinical processes. It also outlines the financial incentives available through Medicare and Medicaid for eligible providers that successfully meet Meaningful Use objectives. The document reviews eligibility, objectives and measures for Stages 1 and 2 of Meaningful Use, and penalties for providers that do not successfully demonstrate Meaningful Use. It provides guidance on determining which version of Meaningful Use objectives a provider must attest to based on their EHR certification year.
The document outlines the opportunities and challenges presented by big data in healthcare. It notes that vast amounts of data are now being generated from sources like genome sequencing, electronic health records, social media, and patient websites. However, simply having large datasets does not guarantee value; the data needs to be analyzed and linked together to generate insights. The document discusses four levels of big data applications from processing large volumes of data to complex modeling. It also examines challenges like developing robust governance, embracing new data uses, overcoming data fragmentation, ensuring data quality and standards, developing innovative analytic methods, addressing skills shortages, and achieving returns on investment. The goal is to improve patient outcomes and healthcare cost-effectiveness through big data.
The future of healthcare is an exciting one. With innovations in genomics, healthcare data, advanced therapies and innovative technologies, our industry will continue to progress and provide hope to people so they can live longer, healthier and productive lives.
The Innovation and Technology Tariff (ITT) aims to incentivize adoption of transformative innovations in the NHS by streamlining pricing and reimbursement. For 2017-19, the first year of the ITT, six themes have been identified that could provide innovation benefits to the NHS at scale. These themes include guided mediolateral episiotomy to minimize obstetric injuries, reducing medication errors, preventing ventilator-associated pneumonia, managing COPD remotely, treating C. difficile infection with frozen fecal transplants, and treating enlarged prostates as outpatients. The ITT operates under both an incentive-based pricing model and a zero-cost model where NHS England covers the cost of approved innovations.
The UK AMR Diagnostic Collaborative aims to maximize the use of diagnostic technology to tackle antimicrobial resistance. It provides single point of focus and leadership for the complex UK diagnostic system. Key areas of focus include diagnostic stewardship, innovation, and addressing unwarranted variation. Upcoming milestones include a national blood culture survey and engagement with industry to accelerate innovative solutions. The collaborative works in partnership across agencies to ensure a responsive diagnostic system.
Presentation on approaches to measure medicine prices and price components, by Marg Ewen, Health Action International, at the launch of the Medicines Transparency Alliance, London 15 May 2008
The EATWELL project aims to benchmark nutrition policies across Europe, evaluate their effectiveness, and recommend new policies. It will assess a range of policy interventions, from information campaigns to market regulations, using modern evaluation techniques. While information policies can support informed choice, their impact on diets is limited. Changing market environments is likely more effective but controversial. Currently, policy evaluations in Europe are rare and unsophisticated. The project hopes to improve the evidence base on what works to promote healthy eating.
With many more people living longer but developing multiple, complex long-term conditions, it has become more important than ever to ensure health systems are fit for future. So how well are health systems across Europe meeting this challenge?
Najibullah Safi, MD, MSc. HPM presented on the history and current state of Afghanistan's health care system. He discussed key progress made in health indicators like immunization coverage and under-five mortality. However, challenges remain such as high stunting rates, poor quality of care in hospitals, and a high maternal mortality ratio. Moving forward, Afghanistan aims to implement an Integrated Package of Essential Health Services to address the triple burden of diseases. Principles of the way forward include prioritizing the poor, increasing community engagement, and raising domestic financing for health.
1. The director of the EMCDDA discussed the evolution of HIV, drugs, and risk behavior in Europe based on lessons learned over decades. New HIV infections attributed to injecting drug use have declined significantly since the 1990s due to effective drug treatment and prevention programs.
2. However, regional disparities remain, and new outbreaks have been linked to stimulant use and new psychoactive substances. Maintaining prevention services and reaching vulnerable groups who are not in care will be important to address ongoing challenges.
3. Going forward, the EMCDDA aims to maintain understanding of drug use trends, identify new health threats to support rapid responses, promote effective interventions, and support policy development - all to contribute to
- Orphanet is an international portal for information on rare diseases and orphan drugs, with its headquarters in France. It began as a French pilot project in 1997 and became a Joint Action of the EU in 2000.
- The portal includes an extensive database on rare diseases, with information on diagnoses, treatments, epidemiology and more. It aims to provide knowledge on rare diseases to healthcare professionals, researchers, patients and caregivers.
- In the UK, Orphanet data was previously contributed through Manchester University but is now managed by Public Health England since 2015.
Strategic directions for the health sector response to viral hepatitis include:
1) Improving surveillance and estimates of disease burden to focus action.
2) Defining essential intervention packages and setting national targets for coverage.
3) Addressing barriers like stigma to make hepatitis services accessible for all populations.
4) Building political commitment and innovative funding approaches for sustainable financing.
5) Prioritizing hepatitis research and rapidly translating findings into practice.
The action plan aims to halt transmission of hepatitis and ensure treatment access for all by 2030.
This document discusses a feasibility study examining whether decisions by the UK's National Institute for Health and Care Excellence (NICE) influence decisions by health technology assessment bodies in other countries. The study analyzed 29 drug-indication pairs assessed by NICE and other countries' HTAs. The results suggest NICE decisions are related to subsequent HTAs in other countries. Drugs without positive NICE recommendations had a higher probability of being not recommended by other HTAs. Additionally, the number of fully reimbursed drugs was higher before versus after NICE assessment. The consideration of NICE decisions may increase the likelihood of other HTAs issuing negative decisions. However, the small sample size means results must be interpreted cautiously and more research is needed.
ROADMAP is a public-private partnership formed under the Innovative Medicines Initiative to develop efficient uses of real world evidence for the benefit of Alzheimer's disease patients and caregivers. It brings together European academic institutions and dementia experts to integrate diverse healthcare data across systems. ROADMAP aims to provide a foundation for an integrated European data environment and framework for using real world evidence to address outcomes in Alzheimer's disease. The initial two year phase will define outcomes measures, identify appropriate data sources, and provide recommendations for disease modeling to regulators and other stakeholders.
Presentation delivered by Dr Kathleen Bennett, Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James’s Hospital at the Irish Pharmaceutical Healthcare Association Meeting 2009.
02.09.09(a): Case Study: Type I Diabetes Overview of Immune Response Open.Michigan
Slideshow is from the University of Michigan Medical
School's M1 Immunology sequence
View additional course materials on Open.Michigan:
openmi.ch/med-M1Immunology
SR is a 29-year-old woman recently diagnosed with type 1 diabetes based on her symptoms of dizziness, fatigue, frequent urination, excessive thirst and hunger, and electrolyte disturbances. Her blood glucose levels were very high at 720 mg/dL and her A1C was 8.5%, indicating her insulin levels were too low and she was not producing enough insulin. Her meal plan needs to be modified using carbohydrate counting to better manage her blood sugar levels, with the goal of keeping her A1C below 7% and blood glucose levels within normal ranges. She should monitor her blood glucose levels before and after exercise and meals to determine how activities and food affect her levels.
Antibiotic resistance is a growing problem that threatens modern medicine. Antibiotic stewardship programs aim to optimize antibiotic treatment and reduce unnecessary use. Such programs coordinate antibiotic prescribing across healthcare facilities in a region to prevent the spread of resistant bacteria. Education is also key - medical students and society must be taught about appropriate antibiotic use and the consequences of misuse. With coordinated antibiotic stewardship and education, the spread of superbugs can be slowed.
This document provides an overview of the Meaningful Use program and regulations. It discusses the stages of Meaningful Use which focus on data capture, sharing, and advanced clinical processes. It also outlines the financial incentives available through Medicare and Medicaid for eligible providers that successfully meet Meaningful Use objectives. The document reviews eligibility, objectives and measures for Stages 1 and 2 of Meaningful Use, and penalties for providers that do not successfully demonstrate Meaningful Use. It provides guidance on determining which version of Meaningful Use objectives a provider must attest to based on their EHR certification year.
The document outlines the opportunities and challenges presented by big data in healthcare. It notes that vast amounts of data are now being generated from sources like genome sequencing, electronic health records, social media, and patient websites. However, simply having large datasets does not guarantee value; the data needs to be analyzed and linked together to generate insights. The document discusses four levels of big data applications from processing large volumes of data to complex modeling. It also examines challenges like developing robust governance, embracing new data uses, overcoming data fragmentation, ensuring data quality and standards, developing innovative analytic methods, addressing skills shortages, and achieving returns on investment. The goal is to improve patient outcomes and healthcare cost-effectiveness through big data.
The future of healthcare is an exciting one. With innovations in genomics, healthcare data, advanced therapies and innovative technologies, our industry will continue to progress and provide hope to people so they can live longer, healthier and productive lives.
The Innovation and Technology Tariff (ITT) aims to incentivize adoption of transformative innovations in the NHS by streamlining pricing and reimbursement. For 2017-19, the first year of the ITT, six themes have been identified that could provide innovation benefits to the NHS at scale. These themes include guided mediolateral episiotomy to minimize obstetric injuries, reducing medication errors, preventing ventilator-associated pneumonia, managing COPD remotely, treating C. difficile infection with frozen fecal transplants, and treating enlarged prostates as outpatients. The ITT operates under both an incentive-based pricing model and a zero-cost model where NHS England covers the cost of approved innovations.
The UK AMR Diagnostic Collaborative aims to maximize the use of diagnostic technology to tackle antimicrobial resistance. It provides single point of focus and leadership for the complex UK diagnostic system. Key areas of focus include diagnostic stewardship, innovation, and addressing unwarranted variation. Upcoming milestones include a national blood culture survey and engagement with industry to accelerate innovative solutions. The collaborative works in partnership across agencies to ensure a responsive diagnostic system.
Presentation on approaches to measure medicine prices and price components, by Marg Ewen, Health Action International, at the launch of the Medicines Transparency Alliance, London 15 May 2008
The EATWELL project aims to benchmark nutrition policies across Europe, evaluate their effectiveness, and recommend new policies. It will assess a range of policy interventions, from information campaigns to market regulations, using modern evaluation techniques. While information policies can support informed choice, their impact on diets is limited. Changing market environments is likely more effective but controversial. Currently, policy evaluations in Europe are rare and unsophisticated. The project hopes to improve the evidence base on what works to promote healthy eating.
With many more people living longer but developing multiple, complex long-term conditions, it has become more important than ever to ensure health systems are fit for future. So how well are health systems across Europe meeting this challenge?
Najibullah Safi, MD, MSc. HPM presented on the history and current state of Afghanistan's health care system. He discussed key progress made in health indicators like immunization coverage and under-five mortality. However, challenges remain such as high stunting rates, poor quality of care in hospitals, and a high maternal mortality ratio. Moving forward, Afghanistan aims to implement an Integrated Package of Essential Health Services to address the triple burden of diseases. Principles of the way forward include prioritizing the poor, increasing community engagement, and raising domestic financing for health.
1. The director of the EMCDDA discussed the evolution of HIV, drugs, and risk behavior in Europe based on lessons learned over decades. New HIV infections attributed to injecting drug use have declined significantly since the 1990s due to effective drug treatment and prevention programs.
2. However, regional disparities remain, and new outbreaks have been linked to stimulant use and new psychoactive substances. Maintaining prevention services and reaching vulnerable groups who are not in care will be important to address ongoing challenges.
3. Going forward, the EMCDDA aims to maintain understanding of drug use trends, identify new health threats to support rapid responses, promote effective interventions, and support policy development - all to contribute to
- Orphanet is an international portal for information on rare diseases and orphan drugs, with its headquarters in France. It began as a French pilot project in 1997 and became a Joint Action of the EU in 2000.
- The portal includes an extensive database on rare diseases, with information on diagnoses, treatments, epidemiology and more. It aims to provide knowledge on rare diseases to healthcare professionals, researchers, patients and caregivers.
- In the UK, Orphanet data was previously contributed through Manchester University but is now managed by Public Health England since 2015.
Strategic directions for the health sector response to viral hepatitis include:
1) Improving surveillance and estimates of disease burden to focus action.
2) Defining essential intervention packages and setting national targets for coverage.
3) Addressing barriers like stigma to make hepatitis services accessible for all populations.
4) Building political commitment and innovative funding approaches for sustainable financing.
5) Prioritizing hepatitis research and rapidly translating findings into practice.
The action plan aims to halt transmission of hepatitis and ensure treatment access for all by 2030.
This document discusses a feasibility study examining whether decisions by the UK's National Institute for Health and Care Excellence (NICE) influence decisions by health technology assessment bodies in other countries. The study analyzed 29 drug-indication pairs assessed by NICE and other countries' HTAs. The results suggest NICE decisions are related to subsequent HTAs in other countries. Drugs without positive NICE recommendations had a higher probability of being not recommended by other HTAs. Additionally, the number of fully reimbursed drugs was higher before versus after NICE assessment. The consideration of NICE decisions may increase the likelihood of other HTAs issuing negative decisions. However, the small sample size means results must be interpreted cautiously and more research is needed.
ROADMAP is a public-private partnership formed under the Innovative Medicines Initiative to develop efficient uses of real world evidence for the benefit of Alzheimer's disease patients and caregivers. It brings together European academic institutions and dementia experts to integrate diverse healthcare data across systems. ROADMAP aims to provide a foundation for an integrated European data environment and framework for using real world evidence to address outcomes in Alzheimer's disease. The initial two year phase will define outcomes measures, identify appropriate data sources, and provide recommendations for disease modeling to regulators and other stakeholders.
Presentation delivered by Dr Kathleen Bennett, Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James’s Hospital at the Irish Pharmaceutical Healthcare Association Meeting 2009.
02.09.09(a): Case Study: Type I Diabetes Overview of Immune Response Open.Michigan
Slideshow is from the University of Michigan Medical
School's M1 Immunology sequence
View additional course materials on Open.Michigan:
openmi.ch/med-M1Immunology
SR is a 29-year-old woman recently diagnosed with type 1 diabetes based on her symptoms of dizziness, fatigue, frequent urination, excessive thirst and hunger, and electrolyte disturbances. Her blood glucose levels were very high at 720 mg/dL and her A1C was 8.5%, indicating her insulin levels were too low and she was not producing enough insulin. Her meal plan needs to be modified using carbohydrate counting to better manage her blood sugar levels, with the goal of keeping her A1C below 7% and blood glucose levels within normal ranges. She should monitor her blood glucose levels before and after exercise and meals to determine how activities and food affect her levels.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise boosts blood flow and levels of neurotransmitters and endorphins which elevate and stabilize mood.
This dental charting document records a patient's chief complaint, medical history, vital signs, clinical exam findings, potential radiology, assessment, treatment plan, and treatment rendered for a dental visit. It includes sections to document the patient's medical conditions and medications, oral exam noting extraoral and intraoral abnormalities, endodontic testing results, diagnosis, proposed treatment, and work done at this appointment.
Case Study On Type 2 diabetes and diabetes related complicationsZohaib HUSSAIN
Insulin resistance increases the risk of developing prediabetes and type 2 diabetes. Prediabetes occurs when blood glucose or A1C levels are higher than normal but not high enough to be diagnosed as diabetes, and it often develops in people with insulin resistance. Although insulin resistance alone does not cause type 2 diabetes, it can lead to the disease by overworking the insulin-producing beta cells. In prediabetes, the beta cells can no longer produce enough insulin to overcome insulin resistance, causing blood glucose levels to rise above the normal range. Once a person has prediabetes, the ongoing loss of beta cell function usually leads to type 2 diabetes.
Type 2 diabetes is the most common form of diabetes, affecting the body's ability to properly process blood sugar. It is a chronic, progressive disease where the body becomes resistant to insulin or does not produce enough insulin. Common symptoms include frequent urination, excessive thirst, hunger, fatigue, and blurred vision. Tests like fasting glucose, oral glucose tolerance, and A1c can diagnose type 2 diabetes. Treatment involves lifestyle changes, oral medication, or insulin depending on the individual case.
For FOP2 Child Life Studies
Please note that this presentation is posted to share with the class. The information has been sited on a handout they received.
A case scenario is a detailed report about a company, industry, person, or project over a period of time. Case studies tell the story of a product or service and customer, interviewing the customer. Case scenarios are used in group discussions to allow students to take on roles in business situations. A case scenario should include basic company information, history, strengths/weaknesses, current business, recommendations. They strengthen practical thinking and allow applying knowledge to new situations. Case scenarios can be factual, based on real situations, or fictional.
Patient Assessment And Clinical Interviewingdunerafael
The document provides guidance on common mistakes healthcare practitioners make in patient communication and assessment. It discusses the importance of greeting patients, understanding their concerns, asking open-ended questions, being attentive to verbal and non-verbal cues, avoiding judgements, and understanding cultural beliefs. It also outlines key information to collect during a patient assessment, including medical history, medications, allergies and social factors, and provides examples of documentation through a SOAP note.
This 57-year-old man with type 2 diabetes, obesity, and hypothyroidism presents for follow-up. He has high blood pressure, dyslipidemia, and early-stage diabetic nephropathy. Treatment is recommended including metformin, an ACE inhibitor, and statin to control blood sugar, blood pressure, and cholesterol. Lifestyle modifications including diet, exercise, and weight loss are also emphasized to manage his conditions. Monitoring of labs and symptoms is planned to assess treatment effectiveness and prevent further complications.
This document discusses case studies, providing definitions, benefits, drawbacks, and tips for writing case studies. It notes that case studies provide detailed observations of individuals or organizations to gain insights. They can produce more detailed pictures than other methods and help generate hypotheses, but the subjects may not be representative. There are two types - factual cases about real situations and fictional cases that use hypothetical scenarios. The document outlines advantages and disadvantages of each type and provides formatting guidelines for writing case studies.
format of case study : a Nursing point of view. it includes all the headings or points about which the information regarding the patient needs to be collected and helps to write a detailed case study
This social case study report documents a family seeking assistance. It identifies the grantee and family members, describes the presenting problems from the client and case worker's perspectives, and provides background on the client's bio-psycho-social history and the family's socio-economic status and environment. The report assesses the family's current functioning, strengths and limitations, prioritizes problems, and outlines intervention plans to address economic sufficiency, program compliance, health, and education goals. Recommendations for priority actions complete the report.
The document provides an overview of diabetes mellitus, including the different types (Type 1, Type 2, gestational), signs and symptoms, causes, and statistical data on prevalence worldwide and in the Philippines. It then discusses a case study of a 71-year old Filipino man diagnosed with diabetes. It outlines his medical history, including a family history of diabetes, and analyzes factors affecting his nutrition and eating patterns such as his beliefs about food, personal preferences for oily and sweet foods, sedentary lifestyle, and lack of religious dietary restrictions.
There are four main types of diabetes: type 1, type 2, gestational diabetes, and pre-diabetes. Type 1 is usually diagnosed in childhood and requires daily insulin injections. Type 2 is the most common type and is often linked to obesity. Gestational diabetes occurs during pregnancy, and pre-diabetes means blood sugar levels are higher than normal but not high enough to be classified as type 1 or 2. Common symptoms of diabetes include frequent urination, thirst, hunger, and fatigue. Testing involves fasting plasma glucose tests and oral glucose tolerance tests. Managing diabetes involves diet, exercise, medication and monitoring blood sugar levels. Long-term complications can affect the heart, kidneys, eyes, nerves and skin if diabetes is
A benefits case study describing how Diabetes UK has used HSCIC's data and statistical outputs to inform the Putting Feet First campaign. https://www.diabetes.org.uk/Get_involved/Campaigning/Our-campaigns/Putting-feet-first/
Map of Medicine provides evidence-based clinical pathways and decision support tools to help standardize patient care across settings. Their solution includes over 260 accredited pathways that can be customized locally. Implementing Map of Medicine's pathways and referral management tools can help reduce unwarranted variation, inappropriate referrals, and shift care to more appropriate settings, achieving benefits like cost savings. Successful localization involves customizing pathways over 6 months to reflect local practices and services.
Current healthcare trends and jobs outlook for 2025needppthelp
This is a team assignment for HCAD 600 for the MS program in Healthcare Administration by UMUC. This presentation is a analysis of the current healthcare trends and job outlook for 2025 to be presented to the HR committee of Board of Directors of a healthcare organization to address workforce shortages in key healthcare areas.
This study assessed health care costs and utilization among union members from 2008-2010, comparing those who received primary care from providers participating in a public health initiative (PCIP) versus non-participating providers. Members accessing PCIP providers saw a 16% decrease in hospitalizations for chronic conditions, whereas non-PCIP members saw a 15% increase. PCIP access was associated with lower inpatient utilization and costs. Specialty care increased more for PCIP members with diabetes and hypertension. Overall, the results suggest population health initiatives incorporating electronic health records can reduce health care costs by decreasing hospitalizations for better chronic disease management.
Process Improvement in OPD billing by observing Billing Errors and thereby in...Angela Kaul
This document is a project report submitted by Dr. Angela Kaul to the Symbiosis Institute of Health Sciences in partial fulfillment of an MBA degree. The report analyzes billing processes and errors at the Columbia Asia Hospital in Pune, India in order to improve efficiency and increase patient satisfaction. It includes an introduction, literature review on global and Indian healthcare industries, aim and objectives of the study, and an abstract that overviews analyzing billing time/delays, identifying non-value adding steps and errors, and recommending solutions.
Richard Mendelsohn- Beyond 2010: SMART Living Paneleventwithme
The document discusses a digitally enabled citizen program called Birmingham OwnHealth that aims to improve health outcomes for those with chronic diseases. The program provides personalized care plans, information prescriptions, and support for self-management through telehealth and care managers. Initial outcomes include reductions in avoidable hospitalizations and emergency visits, as well as improvements in clinical metrics like HbA1c and blood pressure. An independent university study found participants in the program experienced greater reductions in these measures compared to controls.
Elaine kelly public payment and private provisionNuffield Trust
1) Public health spending in the UK rose faster in the 2000s than in previous decades, while growth of private spending slowed after 2007. The share of NHS-funded treatment provided by non-NHS providers also increased during this period.
2) Analysis of hip and knee replacements showed they increased substantially on the NHS between 2003-2012, with non-NHS providers responsible for over half of the rise. Some increase was due to demographics but there was also evidence of substitution from private to NHS funding.
3) Reforms opened up more NHS-funded care to non-NHS providers but the NHS remained the predominant provider, and further growth of non-NHS providers may be limited by NHS demand and
Elaine Kelly public payment and private provisionNuffield Trust
1) Public health spending in the UK rose faster in the 2000s than in previous decades, while growth of private spending slowed after 2007. The share of NHS-funded treatment provided by non-NHS providers also increased during this period.
2) Analysis of hip and knee replacements showed they increased substantially on the NHS between 2003-2012, with non-NHS providers responsible for over half of the rise. Some increase was due to demographics but there was also evidence of substitution from private to NHS funding.
3) Reforms opened up more NHS-funded care to non-NHS providers but the NHS remained the predominant provider, and further growth of non-NHS providers may be limited by NHS demand and
This document presents a framework for using data and technology to transform health and care outcomes in England by 2020. It identifies challenges facing the current system and proposes 12 actions to enable citizens to make healthy choices, give care professionals access to real-time patient data, make care quality transparent, build public trust in data sharing, support innovation, ensure staff can use technology, and get best value for taxpayers. The National Information Board will oversee implementing the framework through national support, local support, and development principles to help the health and care system meet its challenges.
Remedy SNF Performance Network White Paper 2_2016 (Footnoted)Catherine Olexa
The document discusses CMS's focus on reducing costs in post-acute care. It notes that post-acute care spending more than doubled from 2001 to 2013, yet there is little correlation between higher spending and better quality. CMS is aiming to link 50% of Medicare payments to quality by 2018 to control unsustainable spending growth. The document advocates for narrowing post-acute networks to include only high-performing and low-cost skilled nursing facilities, which can reduce costs and readmissions while maintaining or improving quality of care.
National Diabetes Audit (NDA) Care Processes and Treatment Targets 2013-15 Laura Fargher
The National Diabetes Audit (NDA) continues to provide a comprehensive view of Diabetes Care in England and Wales and measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales.
This national report presents the key findings and recommendations on care processes and treatment target achievement rates from 2013-2015 in all age groups in England and Wales along with information on offers and attendance for structured education places.
The National Diabetes Audit 2014-2015 report provides data on care processes and treatment targets for people with diabetes in England and Wales. The report found that while blood pressure and glucose control have improved for some groups, younger people and those under 65 are less likely to receive recommended care processes and treatment targets. There remains significant variation in care provision between practices, services, and regions. The report recommends continued focus on improving outcomes, investigating reasons for underperformance in certain groups, and supporting full participation in the audit to allow for shared learning.
This document discusses the need for quality improvement in the US healthcare system. It notes that while the US leads in medical innovation, care is often fragmented and inconsistent. Several organizations have found issues with the accessibility and quality of care received. The objectives of proposed changes are to prioritize patient safety and deliver the highest quality care nationwide through better education and training. The rationale includes reports that many Americans don't receive recommended care, quality varies greatly between groups, and 30% of healthcare spending has no benefit to patients. Literature supports that most medical errors stem from flawed systems and processes, not individuals, highlighting the need for quality and safety improvements.
Time to Think Differently: The case for changeThe King's Fund
Our Time to Think Differently programme has made the case for change and highlighted the trends that will influence the way health and social care is delivered in future.
To help you explore and share this work, we are creating a series of downloadable slidepacks. We hope that they will inform your thinking and discussions about the future of care.
The first pack in this series explores the pressures on the health and social care delivery system and why it needs to change to meet the challenges of the future.
From High Hopes to HITECH: Money and Meaningful Use. Centricity Healthcare User Group. This presentation covers meaningful use, IT Adoption, interoperability, network effects, transparency and better outcomes from the use of Health Information Technology.
The document summarizes the progress of the NHS in England between 1997 and 2010 based on criteria for a high-performing health system. Key successes included reducing waiting times, establishing clinical standards, and improved health outcomes for major diseases. However, challenges remained around access to services, health inequalities, patient experience in mental health, and demonstrating value for money. Moving forward, ensuring consistent quality and addressing long-term conditions would be priorities in light of tighter budgets.
The document discusses the impact of the American Recovery and Reinvestment Act (ARRA) and the Health Information Technology for Economic and Clinical Health (HITECH) Act on adoption of electronic health records and health information technology in the US. It outlines the large amounts of funding provided through these acts to incentivize meaningful use of EHRs and health information exchange through programs like Medicaid and Medicare incentives and regional extension centers. Stage 1 meaningful use criteria are focused on electronically capturing health information and using it for care coordination and quality reporting.
Sir Muir Gray, Chief Knowledge Officer, NHS intoduces the NHS Atlas of Variation, to show show the NHS are maximising values for populations and individuals.
Similar to Benefits case study summary: Diabetes Uk Putting Feet First Campaign (20)
HSCIC/ESR Data Quality / Data Standards Road Shows 2015/16
The Health and Social Care Information Centre has hosted a series of road shows jointly with the Electronic Staff Record (ESR) Central Team and Health Education England to highlight developments in NHS workforce information, data standards and data quality.
Here are the slides presented at the fourth event, held at the Taunton Rugby Club, Taunton on 25th February 2016.
Data quality is all about collaborative working with a shared purpose and this is the main driver behind our road shows during 2015/16. Any efforts to improve data quality should have mutual benefits and should provide a platform for discourse between all involved. Collectively we can ensure that the data that is used to inform decisions about the workforce at local, regional and national level is as accurate as possible. Good data quality can't guarantee good decisions are made, but poor data quality will definitely increase the likelihood of poor decisions and poor outcomes.
SCIC/ESR Data Quality / Data Standards Road Shows 2015/16
The Health and Social Care Information Centre has hosted a series of road shows jointly with the Electronic Staff Record (ESR) Central Team and Health Education England to highlight developments in NHS workforce information, data standards and data quality.
Here are the slides presented at the third event, held at Bruntwood City Tower, Manchester on 1st March 2016.
Data quality is all about collaborative working with a shared purpose and this is the main driver behind our road shows during 2015/16. Any efforts to improve data quality should have mutual benefits and should provide a platform for discourse between all involved. Collectively we can ensure that the data that is used to inform decisions about the workforce at local, regional and national level is as accurate as possible. Good data quality can't guarantee good decisions are made, but poor data quality will definitely increase the likelihood of poor decisions and poor outcomes.
The document outlines the agenda for a data quality and data standards roadshow presented by the Health and Social Care Information Centre. Recent developments in NHS Jobs data quality and the workforce Minimum Data Set are discussed, including issues found and future plans. Future proposed changes to national workforce data standards and codes are also mentioned.
The Health and Social Care Information Centre is hosting a series of road shows jointly with the Electronic Staff Record (ESR) Central Team and Health Education England to highlight developments in NHS workforce information, data standards and data quality.
Here are the slides presented at the second event, held at The Priory Rooms, Birmingham on 26th November 2015.
Data quality is all about collaborative working with a shared purpose and this is the main driver behind our road shows during 2015/16. Any efforts to improve data quality should have mutual benefits and should provide a platform for discourse between all involved. Collectively we can ensure that the data that is used to inform decisions about the workforce at local, regional and national level is as accurate as possible. Good data quality can't guarantee good decisions are made, but poor data quality will definitely increase the likelihood of poor decisions and poor outcomes.
For more information about future events, please contact the team at workforce.dq@hscic.gov.uk
Nicholas Oughtibridge (Principle Author of the Code of Practice for Confidential Information - HSCIC) spoke at the recent "Commissioning in Healthcare show (CiH 2015)".
Areas covered include:
· The role of the code of practice
· What is covered by the Code of Practice on Confidential Information?
· The seven steps in the life of a data collection
· Sharing confidential information with other people to meet legitimate needs
· Plans for revising the Code of Practice on Confidential Information
Julie Henderson (Head of Analytical Services - HSCIC) presented with Shaun Rowark (Technical Analyst, Quality Standards - NICE) at the recent "Commissioning in Healthcare show (CiH 2015) ".
Areas covered include:
· NICE quality standards: These are concise sets of prioritised statements designed to drive measurable quality improvements within a particular area of health or care. Derived from the best available evidence, they can enable commissioners to be confident that the services they are purchasing are high quality, cost effective and focused on driving up quality.
· Real life examples of how quality standards are being used by commissioners, possible barriers to implementation and advice on how to overcome these
· Data available from the HSCIC and how to use these to support the commissioning process
The Intelligent Data Tool (IDT) analyzes data from 14 million annual NHS Pathways calls to provide intelligence about symptom prevalence, performance, and service usage. It turns call data into dashboards that empower commissioners to manage 111/999 contracts by providing filters, symptom trends, and performance management summaries. The IDT is currently in beta testing and will provide wider access if the pilot is successful.
Andy Williams (Chief Executive - HSCIC) spoke at the recent "Healthcare Efficiency Through Technology Expo (HETT 2015)".
Areas covered include:
· Role and remit of the HSCIC
· Summary of important activity from the last 12 months
· HSCIC’s strategy 2015 - 2020
· The big delivery challenges the health and care system faces
Cleveland Henry (Director of NHS Choices - HSCIC) spoke at the recent "Healthcare Efficiency Through Technology Expo (HETT 2015)".
Areas covered include:
· How does analysis of NHS Choices usage help us to understand the public’s health and care information needs?
· What can web analytics and user feedback tell us about the most popular and useful content?
· How does the mass media agenda drive content consumption?
· How has the move to ‘mobile’ changed the demand for information?
· Where next for online information and transactions?
The document summarizes key findings from the 2014-15 Adult Social Care Outcomes Framework annual report. It found that the North East and South East of England had the highest social care-related quality of life scores, while London had the lowest. Overall, 77% of social care service users felt they had control over their daily lives. Several metrics showed declines from 2012-13 to 2014-15, including carer-reported quality of life (from 8.1 to 7.9), carer satisfaction with social services (from 43% to 41%), and the proportion of carers who found it easy to access service information (from 69% to 66%).
The Health and Social Care Information Centre is hosting a series of road shows jointly with the Electronic Staff Record (ESR) Central Team and Health Education England to highlight developments in NHS workforce information, data standards and data quality.
Here are the slides presented at the first event, held at the Royal Marsden NHS Foundation Trust on 1st October 2015.
Data quality is all about collaborative working with a shared purpose and this is the main driver behind our road shows during 2015/16. Any efforts to improve data quality should have mutual benefits and should provide a platform for discourse between all involved. Collectively we can ensure that the data that is used to inform decisions about the workforce at local, regional and national level is as accurate as possible. Good data quality can't guarantee good decisions are made, but poor data quality will definitely increase the likelihood of poor decisions and poor outcomes.
For more information about future events, please contact the team mailto:workforce.dq@hscic.gov.uk <mailto:workforce.dq@hscic.gov.uk>
The document discusses various health metrics and trends among young people in England. It notes that drinking, smoking, and drug use have decreased among secondary school pupils in the last decade. However, fewer children are meeting recommended levels of physical activity. Dental caries remain the most common hospital diagnosis for children aged 5-9. Referral rates for psychological therapies have increased and are twice as high for 15-19 year old female teenagers than males.
Presentation given relating to the HSCIC report 'Focus on the health and care of young people June 2015' by Kate Croft, HSCIC Head of Statistical Response Unit. This took place at the Health+Care event at London's ExCel, on Thursday 25 June 2015.
The document provides details on the Health and Social Care Information Centre's (HSCIC) business plan for 2015/16. It outlines the HSCIC's role, structure, values, strategy, key achievements in 2014/15, and commitments for 2015/16. The plan aims to support wider health system reform by ensuring data protection, establishing shared standards, implementing national services, supporting organizations to use technology and data, and making better use of health information. The commitments are designed to deliver benefits like improved data access and use, trusted statistics, essential technology infrastructure, and reduced data burdens.
CircleBath used PROMs data to identify areas for improvement in their hip and knee replacement procedures. They implemented changes such as enhanced recovery protocols and improved rehabilitation services. This contributed to CircleBath moving from below to above the England average for adjusted health gains on the Oxford Hip and Knee scores between 2011/12 and 2013/14, demonstrating improved patient outcomes.
This is the HSCIC's draft five-year strategy. A consultation is now open, until February 27th, to gather your feedback. Please have your say and help to shape our future. http://bit.ly/16o8zfk
A catalogue of fact sheets has been compiled in order to give journalists an idea of the breadth of statistical information available at the Health and Social Care Information Centre (HSCIC).
These fact sheets cover a range of subjects at a national level broken down by individual subject areas.
Download this fact sheet to understand more about "Contraception".
A catalogue of fact sheets has been compiled in order to give journalists an idea of the breadth of statistical information available at the Health and Social Care Information Centre (HSCIC).
These fact sheets cover a range of subjects at a national level broken down by individual subject areas.
Download this fact sheet to understand more about "Obesity".
A catalogue of fact sheets has been compiled in order to give journalists an idea of the breadth of statistical information available at the Health and Social Care Information Centre (HSCIC).
These fact sheets cover a range of subjects at a national level broken down by individual subject areas.
Download this fact sheet to understand more about "Prescribing".
More from The Health and Social Care Information Centre (20)
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
Hypertension and it's role of physiotherapy in it.
Benefits case study summary: Diabetes Uk Putting Feet First Campaign
1. v1.0
02/12/2015
Benefits case study summary – use of health care data by
Diabetes UK to inform the Putting Feet First campaign
How HSCIC’s Hospital Episode Statistics (HES) data informed the campaign driver
Hospital Episode Statistics (HES) data was used to establish that there are higher rates of amputation in people
with diabetes (2.51 per 1,000 person-years vs 0.11 per 1,000 person-years) and that the number of
amputations in people with diabetes is expected to reach 7,000+ by 2014/15. These two factors, plus the
inpatient expenditure on amputations and the viability of preventing many amputations through changes in care
services and improved awareness, have driven the need for the Putting Feet First campaign.
How HSCIC’s audit data informed the campaign aim and objectives
HES and Quality and outcomes Framework (QOF) data have informed the campaign aim of reducing the
amputation rates in people with diabetes by 50%, by 2017, as measured against the 2009-2012 baseline of 2.6
annual lower limb amputations per 1,000 adults with diabetes. National Diabetes Audit (NDA) and National
Diabetes Inpatient Audit (NaDIA) publications data have informed three of the four campaign objectives:
Ensure people with diabetes have annual foot examinations
Improve access to multi-disciplinary footcare teams (MDFTs)
Increase foot examinations during hospital stay
Examples of promotional activities informed by HSCIC’s statistical data
In July 2012, Diabetes UK published on their website a list of 84 sites in England and Wales that were
without MDFTs in 2011, based on bespoke NaDIA 2011 data HSCIC supplied to Diabetes UK.
In June 2013, Diabetes UK sent letters to 50 clinical commissioning groups (CCGs) and associated NHS
trusts to inform them of high amputation rates in their areas and, where relevant, gaps and concerns in the
NHS trust’s footcare services. HSCIC’s HES, QOF and NaDIA 2012 data informed this activity.
In September 2013, Diabetes UK issued press releases in areas they’d targeted with high amputation rate
letters, with the aim of raising awareness with local people and local stakeholders.
Intermediate benefits (improvements) realised
The behavioural and service changes that are likely to have resulted from the campaign activities have
contributed to the following benefits, as measured between 2011 and 2013:
Percentage of hospital sites with MDFTs increased from 58.3% to 71.8%
Percentage of patients receiving foot examinations during hospital stay increased from 25.8% to 42.4%
Percentage of patients receiving foot examinations within the first 24 hours of their hospital stay increased
from 21.3% to 36.3%.
End benefits anticipated
The intermediate benefits are anticipated to contribute to the following end benefits:
Reduction in amputation rate in people with
diabetes
Fewer people with diabetes experiencing reduced
quality of life
Improved survival rates in people with diabetes Reduced NHS expenditure on amputations
Putting Feet First campaign
In March 2012, Diabetes UK launched the Putting Feet First campaign, which aims to reduce the rate of lower
limb amputations in people with diabetes by 50%, by 2017. The Health and Social Care Information Centre
(HSCIC) has produced a benefits case study describing how the campaign was informed by HSCIC’s data and
statistical outputs and what benefits the campaign is contributing to.
More information
The full Putting Feet First benefits case study can be accessed at:
http://www.hscic.gov.uk/benefitscasestudies/publications